Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Carl Zeiss Meditec (AFX) vs. Competitors

1 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
CH:AFXCarl Zeiss MeditecCHF 32.00CHF 2.85B19.32-81.67%Moderate SellUnlock the CH:AFX analyst price target with TipRanks PremiumCH:AFXUnlock the CH:AFX top-analyst price target with TipRanks Premium
DE:DRW8Draegerwerk AG & Co. KGaAEUR 89.40EUR 1.93B13.1645.13%―Unlock the DE:DRW8 analyst price target with TipRanks PremiumCH:AFX vs DE:DRW8Unlock the DE:DRW8 top-analyst price target with TipRanks Premium
DE:EUZEckert & Ziegler Strahlen und MedizintechnikEUR 14.98EUR 930.47M17.22-5.43%Moderate BuyUnlock the DE:EUZ analyst price target with TipRanks PremiumCH:AFX vs DE:EUZUnlock the DE:EUZ top-analyst price target with TipRanks Premium
DE:JENJenoptikEUR 36.10EUR 2.07B20.7588.51%Strong BuyUnlock the DE:JEN analyst price target with TipRanks PremiumCH:AFX vs DE:JENUnlock the DE:JEN top-analyst price target with TipRanks Premium
DE:SRTSartoriusEUR 229.50EUR 18.12B72.6330.84%Moderate BuyUnlock the DE:SRT analyst price target with TipRanks PremiumCH:AFX vs DE:SRTUnlock the DE:SRT top-analyst price target with TipRanks Premium
DE:SBSSTRATEC BiomedicalEUR 27.35EUR 332.47M-7.8434.73%Moderate BuyUnlock the DE:SBS analyst price target with TipRanks PremiumCH:AFX vs DE:SBSUnlock the DE:SBS top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
CH:AFXCarl Zeiss Meditec32.00-142.60-81.67%
DE:DRW8Draegerwerk AG & Co. KGaA89.4029.1048.26%
DE:EUZEckert & Ziegler Strahlen und Medizintechnik14.98-0.47-3.03%
DE:JENJenoptik36.1017.1190.06%
DE:SRTSartorius229.5054.4631.11%
DE:SBSSTRATEC Biomedical27.357.8740.43%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts